Home Ginseng & Ginsenosides Redsenol Noble Ginsenosides Showcased at CHFA NOW Toronto Show

Redsenol Noble Ginsenosides Showcased at CHFA NOW Toronto Show

194
1
SHARE

Canada Royal Enoch Phytomedicine Ltd., an innovative leader in ginseng and ginsenoside research and application, attended the Canadian Health Food Association (CHFA) NOW Toronto Trade Show, which took place September 18-19, 2022.

The company showcased its two flagship ginseng supplements, Redsenol-1 Noble Ginsenoside Capsules (Redsenol-1) and Redsenol Dag Sublingual Pills (Redsenol Dag).

Redsenol Team & Attendee

Redsenol Series is a game changer for the ginseng supplement industry. Canada Royal Enoch Phytomedicine owns four unique technologies which enable production of rare ginsenoside on a mass scale. While most ginseng supplement brands in the market contain only 5%-10% total ginsenosides, Redsenol contains up to 20% rare noble ginsenosides.

Redsenol has a wide variety of highly bioactive and absorbable rare ginsenosides monomers, including Rg3, Rh2, Rk1, Rg5, Rk2,  aPPD, etc. These different rare ginsenosides have diverse pharmacological activity and they can work synergistically to achieve multifaceted health benefits.

Redsenol-1 features sixteen highly active rare ginsenoside monomers, among which eight super highly bioactive ones are selected to be the main active ingredients for Redsenol Dag sublingual pills.

Redsenol Team & Attendees

Throughout the trade show, Redsenol Noble Ginsenosides gained great interest among attendees. A group of attendees tried Redsenol Dag and felt a difference 30 minutes later. Naturopathic physicians also showed great interest in Redsenol Noble Ginsenosides and they had a wonderful conversation with the Redsenol Team.

Redsenol Team & Naturopathic Physicians

“We’re happy to see Redsenol Noble Ginsenosides loved by so many attendees, including common customers, industry peers, and practitioners. We like this chance to bring Redsenol Noble Ginsenosides to more people,” said Joshua Yu, CEO of Canada Royal Enoch Phytomedicine.

Redsenol Team & KGK Science’s CEO

A surprise visitor is Najla Guthrie, President & CEO of KGK Science Inc., and she was kind to take a special visit to the Redsenol booth.

This year, Redsenol formed a partnership with KGK Science to conduct Redsenol clinical trial, and KGK Science is a leading contract research organization in Canada that provides high-quality clinical research trials.

About Canada Royal Enoch Phytomedicine Ltd. & Redsenol

Canada Royal Enoch Phytomedicine Ltd. is a biotech enterprise group mainly engaged in the research, production and sales of natural plant-based products. Redsenol® by Canada Royal Enoch Phytomedicine Ltd. is a top ginseng brand featuring multicomponent rare ginsenosides in high concentration. The core technologies owed by the company in rare ginsenoside extraction, processing, transformation, and formulation enable the preparation of easily absorbable rare ginsenosides in large amounts.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here